key: cord-0986197-f91pla97
authors: Yin, Lu; Adotama, Prince; Svigos, Katerina; Gutierrez, Daniel; Lo Sicco, Kristen
title: Platelet-rich plasma, a promising adjunctive treatment for vitiligo: A case report
date: 2020-10-08
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2020.09.021
sha: c47e1bc23e9d2631092f5f2ca85f9c7714ec3087
doc_id: 986197
cord_uid: f91pla97

nan

Vitiligo is an autoimmune disorder that targets and destroys melanocytes, resulting in skin 25 depigmentation. 1 A potentially highly visible condition, vitiligo may be stigmatizing and 26 distressing for patients. 2 Platelet-rich plasma (PRP) contains high concentrations of platelets and 27 growth factors and is an increasingly popular treatment for androgenetic alopecia (AGA). 3 While 28 the use of PRP to treat AGA has been documented, its utility in treating vitiligo is still in the 29 initial stages of investigation. 4-6 Here, we present a case of a 39-year-old male who had 30 improvement in his vitiligo after phototherapy and PRP injections. (monthly, 3 treatments total) and NB-UVB (three times a week) was continued for two months, 52 resulting in greater than 50% improvement over baseline (good response), 5 involving his eyelids 53 and eyebrows, frontal scalp, and temples (Fig. 1) . Due to the COVID-19 pandemic, he 54 continued repigmentation with greater than 75% improvement from baseline (excellent 56 response), 5 on the face and scalp without any specific signs of vitiligo worsening on dermoscopy 57 (Fig. 1) . While PRP induces micro-trauma in the skin, there were no clinical or dermoscopic 58 signs of koebnerization in our patient. 

Quality of Life, Burden of Disease, Co-morbidities, and Systemic 107 Effects in Vitiligo Patients

Trichologic response of platelet-rich plasma in 109 androgenetic alopecia is maintained during combination therapy

Evaluation of combined excimer laser and platelet-rich 112 plasma for the treatment of nonsegmental vitiligo: A prospective comparative study